Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jupiter Neurosciences, Inc. - Common Stock (NQ:JUNS)

1.060 +0.030 (+2.91%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 86,871
Open 1.060
Bid (Size) 1.050 (100)
Ask (Size) 1.110 (400)
Prev. Close 1.030
Today's Range 1.030 - 1.080
52wk Range 0.5100 - 9.350
Shares Outstanding 34,426,355
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
From FDA Clearance To The Launch Of A Consumer Line, Jupiter Neurosciences Hit Milestones In 2025; More On The Horizon
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
From FDA Clearance To The Launch Of A Consumer Line, Jupiter Neurosciences Hit Milestones In 2025; More On The Horizon
Via TheNewswire.com

Performance

YTD
+5.0%
+5.0%
1 Month
-6.2%
-6.2%
3 Month
-34.2%
-34.2%
6 Month
-44.5%
-44.5%
1 Year
-87.7%
-87.7%

More News

Read More
News headline image
Jupiter Neurosciences Brings Its Brain Health Expertise To The Masses With Nugevia - And A Range Of Celebs From Athletes To Scientists Are Customers
Via NewMediaWire
News headline image
Jupiter Neurosciences Brings Its Brain Health Expertise To The Masses With Nugevia - And A Range Of Celebs From Athletes To Scientists Are Customers
Via TheNewswire.com
News headline image
Jupiter Neurosciences CEO And President Talk About The Power of JOTROL And The Launch of Its Longevity Consumer Line With Benzinga
Via TheNewswire.com
News headline image
Jupiter Neurosciences CEO And President Talk About The Power of JOTROL And The Launch of Its Longevity Consumer Line With Benzinga
Via NewMediaWire
News headline image
Longevity In A Capsule: Jupiter Neurosciences Launches First Three Supplements Under Nugevia(TM) Brand
Via NewMediaWire
News headline image
Longevity In A Capsule: Jupiter Neurosciences Launches First Three Supplements Under Nugevia(TM) Brand
Via TheNewswire.com
News headline image
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Via Benzinga
News headline image
From Fighting Inflammation To Regenerating Cells: How Jupiter Neurosciences Is Putting The Pep Back In Our Step As We Age
Via NewMediaWire
News headline image
From Fighting Inflammation To Regenerating Cells: How Jupiter Neurosciences Is Putting The Pep Back In Our Step As We Age
Via TheNewswire.com
News headline image
Which stocks are moving after the closing bell on Friday? ↗
Via Chartmill
News headline image
Top movers in Thursday's after hours session ↗
Via Chartmill
News headline image
Top stock movements in today's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Via Chartmill
News headline image
How Jupiter Neuroscience's Two-Prong Approach Could Crack The Code On Biotech Success
Via NewMediaWire
News headline image
How Jupiter Neuroscience's Two-Prong Approach Could Crack The Code On Biotech Success
Via TheNewswire.com
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Via Benzinga
News headline image
Here are the top movers in Thursday's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
Unusual volume stocks are being observed in Thursday's session. ↗
Via Chartmill

Frequently Asked Questions

Is Jupiter Neurosciences, Inc. - Common Stock publicly traded?
Yes, Jupiter Neurosciences, Inc. - Common Stock is publicly traded.
What exchange does Jupiter Neurosciences, Inc. - Common Stock trade on?
Jupiter Neurosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Jupiter Neurosciences, Inc. - Common Stock?
The ticker symbol for Jupiter Neurosciences, Inc. - Common Stock is JUNS on the Nasdaq Stock Market
What is the current price of Jupiter Neurosciences, Inc. - Common Stock?
The current price of Jupiter Neurosciences, Inc. - Common Stock is 1.060
When was Jupiter Neurosciences, Inc. - Common Stock last traded?
The last trade of Jupiter Neurosciences, Inc. - Common Stock was at 01/09/26 04:00 PM ET
What is the market capitalization of Jupiter Neurosciences, Inc. - Common Stock?
The market capitalization of Jupiter Neurosciences, Inc. - Common Stock is 36.49M
How many shares of Jupiter Neurosciences, Inc. - Common Stock are outstanding?
Jupiter Neurosciences, Inc. - Common Stock has 36M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.